Showing results (31-40 of 40) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
International Journal of Laboratory Hematology|August 13, 2021
Mutational landscape of Juvenile Myelomonocytic Leukemia (JMML)-A real-world contextShrinidhi Nathany, Gaurav Chatterjee, Shruti Ghai, et al.Cureus|February 24, 2026
Letermovir Prophylaxis for Cytomegalovirus Infection in Adult Allogeneic Stem Cell Transplantation: A Retrospective Analysis From a Lower-Middle-Income CountryNeha Rastogi, Swati Bhayana, Kapil Chahal, et al.Hemoglobin|October 5, 2025
Encouraging Outcomes of Hematopoeitic Stem Cell Transplantation in Pediatric Sickle Cell Disease- A Decade-Long Experience from the Developing WorldSwati Bhayana, Sohini Chakaroborty, Shrinidhi Nathany, et al.The Lancet Regional Health. Southeast Asia|May 17, 2024
AI-based pipeline for early screening of lung cancer: integrating radiology, clinical, and genomics dataUllas Batra, Shrinidhi Nathany, Swarsat Kaushik Nath, et al.Journal of Pediatric Hematology/Oncology|December 8, 2025
Excellent Outcomes of Hematopoietic Stem Cell Transplant for Pediatric High Risk and Relapsed Acute Myeloid Leukemia-A Decade Long Experience From Developing NationSunisha Arora, Arun S Danewa, Sohini Chakraborty, et al.The British Journal of Radiology|December 21, 2022
Tri-modality therapy in advanced esophageal carcinoma: long-term results and insights from a developing world, institutional cohortKundan Singh Chufal, Irfan Ahmad, Ram Bajpai, et al.South Asian Journal of Cancer|December 22, 2025
A Study of Molecular Subtypes (Profile) of Colorectal Cancer and Their Correlation with Clinical and Pathological Profile in a Tertiary Care Center in IndiaSrujana Joga, Sumit Goyal, Anurag Mehta, et al.Oncology and Therapy|October 17, 2025
A Decade of Treating ALK-Rearranged Non-Small Cell Lung Cancer in a Lower Middle-Income Country: Changing Patterns and Improving SurvivalUllas Batra, Mansi Sharma, Irfan Ahmad, et al.Immunotherapy|September 5, 2025
First-line pembrolizumab for metastatic NSCLC in lower-middle-income countries: bridging the efficacy-effectiveness gapUllas Batra, Mansi Sharma, Alexis Andrew Miller, et al.The Lancet Regional Health. Southeast Asia|August 19, 2024
Uniqueness of lung cancer in Southeast AsiaVanita Noronha, Atul Budukh, Pankaj Chaturvedi, et al.Pageof 4